Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Notable: Non-Surgical Periodontal Treatment on Inflammatory and Bone Markers in Periodontitis Patients Enrollment reopened Saglik Bilimleri UniversitesiNot applicable NCT07475013
  2. Notable: Using the Babble Boot Camp© Speech Therapy Approach With Babies Born Prematurely Recruitment opened Murdoch Childrens Research InstituteNot applicable NCT07738224
  3. Notable: Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in Schizophrenia Recruitment opened Central South UniversityNot applicable NCT07806877
  4. Notable: Predictive Value of Microemboli Detected by Robotic Transcranial Doppler (TCD) for the Occurrence of an Acute Ischemic Stroke (AIS) or Left Ventricular Thrombus (LVT) in ST Elevation Myocardial Infarction (STEMI) · Left Ventricular Dysfunction (LVD) Recruitment opened CHC MontlegiaNot applicable NCT07932080
  5. Notable: Between Opioid-sparing Anesthesia Guided by the CARDEAN® Index and Opioid-free Anesthesia During Total Hip Arthroplasty Recruitment opened Pole Sante Oreliance, Polyclinique des Longues AlleesNot applicable NCT07747142
  6. Notable: Synthetic Mesh · HernIa After opEn Abdomen cLosure stuDy Recruitment opened Hospital San Juan de Dios TenerifeNot applicable NCT07835334
  7. Notable: Hydromorphone Sustained-Release Tablets in Elderly Cancer Pain · Renal Insufficiency Recruitment opened Taian Cancer HospitalNot specified NCT07421674
  8. Notable: Correlation Between Forward Head Posture and Executive Functions in Cervical Radiculopathy Recruitment opened Cairo UniversityNot specified NCT07906847
  9. Notable: Online Pain Education for Crohn's Disease and Ulcerative Colitis Enrolling by invitation only Cedars-Sinai Medical CenterNot applicable NCT07671313
  10. Notable: Laser Irradiation on the Veins and Acupoints on Arterial Stiffness · Cardio-renal Metabolic Syndrome Enrolling by invitation only National Yang Ming Chiao Tung UniversityNot specified NCT07543211
  11. Notable: Biomarker Investigation for Early Gastric Cancer Detection Recruitment opened Centre Leon BerardNot applicable NCT07884669
  12. Notable: Outcome of Concurrent Versus Sequential Method of Induction of Labour in Term Pregnancy Recruitment opened Khyber Medical University PeshawarNot applicable NCT07821099
  13. Notable: GLP-1RAs on Fertility Outcomes in Obese · PCOS Recruitment opened Peking University Third HospitalNot applicable NCT07687667
  14. Notable: Orofacial Myofunctional Therapy and Cervical Stabilization Exercises · Axis-i Group Iia Temporomandibular Dysfunction Recruitment opened University of LahoreNot applicable NCT07853144
  15. Notable: Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1 Recruitment opened Henry M. Jackson Foundation for the Advancement of Military MedicineNot specified NCT07249762
  16. Notable: Sibeprenlimab in Children and · Immunoglobulin A Nephropathy (IgAN) Start date pushed from Oct 30, 2026 to Nov 30, 2026 Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3 NCT07770815
  17. Notable: T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd Start date pushed from Sep 18, 2026 to Nov 4, 2026 Daiichi SankyoPhase 3 NCT07683754
  18. Notable: Adjunctive Troriluzole in Obsessive Compulsive Disorder Results posted: Nov 17, 2026 Biohaven Pharmaceuticals, Inc.Phase 3 NCT04641143
  19. Notable: INCB123667 Versus Investigator's Choice of Chemotherapy · Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression Primary and study completion dates moved earlier to Oct 12, 2027 Incyte CorporationPhase 3 NCT07214779
  20. Notable: Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response Eligibility criteria changed NanOlogy, LLC (doing business as Intryx Therapeutics, LLC)Phase 1/2 NCT07767110
  21. Notable: Topical SGX302 for Mild-to-Moderate Psoriasis Results posted: Nov 17, 2026 SoligenixPhase 2 NCT05442190
  22. Notable: NAI Plus Standard of Care Compared To SOC Alone Plus Standard of Care · Sepsis Start date pushed from Oct 15, 2026 to Jan 15, 2027 ImmunityBio, Inc.Phase 2 NCT07783789
  23. Notable: LY4405094 in Healthy Participants and · Alzheimer's Disease Start date pushed from Oct 14, 2025 to Oct 10, 2026 Eli Lilly and CompanyPhase 1 NCT07787182
  24. Notable: THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator · Drug Refractory Symptomatic PAFOUS Results posted: Nov 17, 2026 Biosense Webster, Inc.Not applicable NCT06272981
  25. Notable: Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease Eligibility criteria changed Vastra Gotaland RegionPhase 3 NCT07932314